Biologic manufacturing ensures a consistent supply of high-quality drugs throughout their lifecycle. The production process includes drug substance manufacturing, divided into upstream and downstream stages, and drug product manufacturing, which covers formulation, filling, labeling, and packaging. Preventing microbial contamination is critical and achieved by using closed systems and operating in clean rooms as per regulatory guidelines. Good Manufacturing Practices (GMP) form the foundation of biologics production, requiring predefined specifications for equipment and materials, standardized procedures, and comprehensive documentation to ensure product quality and compliance. Before commercial use, the manufacturing process undergoes validation to demonstrate its robustness and consistency. Once validated, any changes to the process or facility require regulatory approval. Key commercial considerations include scheduling, capacity planning, inventory management, and supply chain optimization to meet market demands while controlling costs. Emerging trends in biologics manufacturing, such as continuous production, personalized therapies, automation, and digital technologies, are driving efficiency and innovation in the field. These advancements promise to improve scalability, reduce costs, and enhance product accessibility while maintaining stringent quality standards. Together, these practices and innovations ensure the safe and reliable delivery of biologic drugs to patients worldwide.